Phase 2 Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial has three groups. You may qualify for one of them:
Group A – Sickle cell disease with heart stiffness (diastolic dysfunction):
- You are between 18 and 21 years old
- You identify as Black
- You have been diagnosed with sickle cell disease of the HbSS or HbSβ0 thalassemia type (confirm with trial site)
- You have three or more abnormal results on a heart ultrasound test measuring how well your heart relaxes (confirm with trial site)
Group B – Sickle cell disease without heart stiffness:
- You are between 18 and 21 years old
- You identify as Black
- You have been diagnosed with sickle cell disease of the HbSS or HbSβ0 thalassemia type (confirm with trial site)
- You have two or fewer abnormal results on a heart ultrasound test measuring how well your heart relaxes (confirm with trial site)
Group C – Healthy volunteers (no sickle cell disease):
- You are between 18 and 21 years old
- You identify as Black
- You have two or fewer abnormal results on a heart ultrasound test measuring how well your heart relaxes (confirm with trial site)
Who may not be able to join:
- You were hospitalized in the last 4 weeks for a sickle cell pain crisis or a serious lung complication called acute chest syndrome (applies to Groups A and B)
- You received a blood transfusion in the last 3 months (applies to Groups A and B)
- You have any form of sickle cell disease (applies to Group C only)
- You have moderate or severe anemia at your first study visit (applies to Group C only)
- You currently have signs, symptoms, or abnormal heart test results suggesting a heart attack or severe chest pain (unstable angina)
- You have a history of serious abnormal heart rhythms, including ventricular tachycardia, ventricular fibrillation, or supraventricular tachycardia (confirm with trial site)
- You have had heart surgery in the past
- You have a known heart defect present from birth (with the exception of a patent ductus arteriosus or atrial septal defect — confirm with trial site)
- You have narrowing (stenosis) of your heart valves or the main artery supplying your heart
- You have a history of inflammation of the heart muscle or the sac around the heart (myocarditis or pericarditis)
- Your heart's main pumping chamber does not squeeze properly (left ventricle dysfunction)
- You have uncontrolled high blood pressure or a history of a blood pressure emergency
- You have a history of problems with your heart's natural pacemaker or serious blockages in the heart's electrical system (confirm with trial site)
- You have a history of sudden cardiac arrest or cardiac death that was reversed
- You currently have a seizure disorder and are taking anti-seizure medication
- You are pregnant or breastfeeding
- The trial doctors believe, for any medical or personal reason, that joining would not be in your best interest
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Parul Rai, MD, St. Jude Children's Research Hospital
Phone: 888-226-4343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mean and standard deviation of coronary flow reserve (CFR); CFR difference among Stratum A, Stratum B, and Stratum C
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.